PD62: Bladder Cancer: Upper Tract Transitional Cell Carcinoma II

5/6/2019

7:00 AM - 9:00 AM

Location: MCP: W184d

Abstract Presenter(s)

Kareem Alazem, MD

Lahey Hospital and Medical Center
AB

Aaron Berkenwald

Slides
AG

Andrea Gallioli, MD

Fundacio Puigvert, Barcelona
Bogdan Geavlete, MD, PhD

"Carol Davila" University of Medicine, Bucharest, Romania

Slides
Sinan Khadhouri, MBBS

Aberdeen Royal Infirmary
FK

Fumitaka KOGA
AS

Andrew Silagy
Nirmish Singla, MD

University of Texas Southwestern Medical Center
SS

Si Sung, MD

Samsung medical center
AV

Andrew Vitale, MD

University of Iowa Hospitals and Clinics
Brian Winters, MD

University of Washington
SZ

Stefania Zamboni, MD

Presentations:

7:00 AM - 7:10 AM
IDENTIFY: The Investigation and DEtection of urological Neoplasia in paTIents reFerred with suspected urinarY tract cancer: A multicentre analysis
Sinan Khadhouri, MBBS
7:10 AM - 7:20 AM
The crucial role of ureteroscopy in the diagnostic/therapeutic pathway of upper tract urothelial carcinoma
Andrea Gallioli, MD
7:20 AM - 7:30 AM
NBI-assisted digital flexible ureteroscopy versus the standard white light evaluation in transitional renal cell carcinoma – A pathological analysis’ evidence-based, prospective diagnostic accuracy comparison
Bogdan Geavlete, MD, PhD
7:30 AM - 7:40 AM
Role of diffusion-weighted MRI in in predicting ≥pT2 and ≥pT3 upper tract urothelial cancer
Fumitaka KOGA
7:40 AM - 7:50 AM
The impact of histological variants on survival in in upper urinary tract urothelial carcinoma patients treated with nephroureterectomy: a multicenter collaboration
Stefania Zamboni, MD
7:50 AM - 8:00 AM
Distinct Genomic Hallmarks Exist Between Metastatic Upper and Lower Tract Urothelial Carcinoma
Brian R. Winters, MD – University of Washington Medical Center
8:00 AM - 8:10 AM
Propensity-score mathched comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy
Si Hyun Sung, MD
8:10 AM - 8:20 AM
Using microRNA Expression from Biopsy Samples in Upper Tract Urothelial Carcinoma as a Predictive Model for Tumor Grade and Invasion
Aaron Berkenwald
8:20 AM - 8:30 AM
MicroRNAs as biomarkers to determine risk of bladder cancer recurrence following nephroureterectomy for upper tract urothelial carcinoma
Kareem Alazem, MD
8:30 AM - 8:40 AM
Topical Treatment for High-Grade Upper Tract Cytology with Negative Imaging (HGUTCNI)
Andrew M. Vitale, MD MS
8:40 AM - 8:50 AM
PATHOLOGIC STAGE AS A SURROGATE FOR ONCOLOGIC OUTCOMES AFTER RECEIPT OF NEOADJUVANT CHEMOTHERAPY FOR HIGH-GRADE UPPER TRACT UROTHELIAL CARCINOMA
Nirmish Singla, MD
8:50 AM - 9:00 AM
Does Mutational Burden Affect Response to Cisplatin-based Neoadjuvant Chemotherapy in Upper Tract Urothelial Carcinoma?
Andrew Silagy